Immundiagnostik Ltd 13536777 false 2022-08-01 2023-07-31 2023-07-31 The principal activity of the company is a dormant company. Digita Accounts Production Advanced 6.30.9574.0 true 13536777 2022-08-01 2023-07-31 13536777 2023-07-31 13536777 bus:Micro-entities 2022-08-01 2023-07-31 13536777 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 13536777 bus:FullAccounts 2022-08-01 2023-07-31 13536777 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 13536777 bus:RegisteredOffice 2022-08-01 2023-07-31 13536777 bus:Director1 2022-08-01 2023-07-31 13536777 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 13536777 countries:EnglandWales 2022-08-01 2023-07-31 13536777 2021-07-29 2022-07-31 13536777 2022-07-31 iso4217:GBP xbrli:pure

Registration number: 13536777

Immundiagnostik Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2023

 

Immundiagnostik Ltd

Contents of the Financial Statements
for the Year Ended 31 July 2023

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Immundiagnostik Ltd

Company Information






 

Director

Dr F P Armbruster

Registered office

Stanhope House
Mark Rake
Wirral
Merseyside
CH62 2DN



 

Accountants

Pennington Williams Limited
Chartered Certified Accountants
Stanhope House
Mark Rake
Bromborough
Wirral
Merseyside
CH62 2DN

 

Immundiagnostik Ltd

(Registration number: 13536777)
Balance Sheet as at 31 July 2023

2023
£

2022
£

Current assets

100

100

Capital and reserves

100

100


 

Notes To The Financial Statements

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Stanhope House
Mark Rake
Wirral
Merseyside
CH62 2DN
United Kingdom

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 0).

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

Immundiagnostik Ltd

(Registration number: 13536777)
Balance Sheet as at 31 July 2023

Approved and authorised by the director on 23 April 2024
 

.........................................

Dr F P Armbruster
Director